These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
130 related items for PubMed ID: 1351796
1. Onset of action of loratadine and placebo and other efficacy variables in patients with seasonal allergic rhinitis. Bédard PM, Del Carpio J, Drouin MA, Yang W, Hébert J, Lavoie A, Prévost M, Turenne Y, PetitClerc C, Lorber R. Clin Ther; 1992; 14(2):268-75. PubMed ID: 1351796 [Abstract] [Full Text] [Related]
2. A multicentric study of loratadine, terfenadine and placebo in patients with seasonal allergic rhinitis. Horak F, Bruttmann G, Pedrali P, Weeke B, Frølund L, Wolff HH, Christophers E. Arzneimittelforschung; 1988 Jan; 38(1):124-8. PubMed ID: 2896508 [Abstract] [Full Text] [Related]
3. Double-blind comparison of loratadine (SCH 29851), astemizole, and placebo in hay fever with special regard to onset of action. Oei HD. Ann Allergy; 1988 Dec; 61(6):436-9. PubMed ID: 2904776 [Abstract] [Full Text] [Related]
4. Cetirizine, loratadine, or placebo in subjects with seasonal allergic rhinitis: effects after controlled ragweed pollen challenge in an environmental exposure unit. Day JH, Briscoe M, Widlitz MD. J Allergy Clin Immunol; 1998 May; 101(5):638-45. PubMed ID: 9600501 [Abstract] [Full Text] [Related]
5. A comparison of the efficacy of fluticasone propionate aqueous nasal spray and loratadine, alone and in combination, for the treatment of seasonal allergic rhinitis. Ratner PH, van Bavel JH, Martin BG, Hampel FC, Howland WC, Rogenes PR, Westlund RE, Bowers BW, Cook CK. J Fam Pract; 1998 Aug; 47(2):118-25. PubMed ID: 9722799 [Abstract] [Full Text] [Related]
6. Comparative onset of action and symptom relief with cetirizine, loratadine, or placebo in an environmental exposure unit in subjects with seasonal allergic rhinitis: confirmation of a test system. Day JH, Briscoe M, Rafeiro E, Chapman D, Kramer B. Ann Allergy Asthma Immunol; 2001 Dec; 87(6):474-81. PubMed ID: 11770694 [Abstract] [Full Text] [Related]
7. Loratadine-pseudoephedrine combination versus placebo in patients with seasonal allergic rhinitis. Grossman J, Bronsky EA, Lanier BQ, Linzmayer MI, Moss BA, Schenkel EJ, Selner JC. Ann Allergy; 1989 Oct; 63(4):317-21. PubMed ID: 2529798 [Abstract] [Full Text] [Related]
8. Relative efficacy and safety of loratadine, hydroxyzine, and placebo in chronic idiopathic urticaria and atopic dermatitis. Monroe EW. Clin Ther; 1992 Oct; 14(1):17-21. PubMed ID: 1349509 [Abstract] [Full Text] [Related]
9. Safety and efficacy of loratadine (Sch-29851): a new non-sedating antihistamine in seasonal allergic rhinitis. Dockhorn RJ, Bergner A, Connell JT, Falliers CJ, Grabiec SV, Weiler JM, Shellenberger MK. Ann Allergy; 1987 Jun; 58(6):407-11. PubMed ID: 2954497 [Abstract] [Full Text] [Related]
10. Efficacy of loratadine versus placebo in the prophylactic treatment of seasonal allergic rhinitis. Dolovich J, Moote DW, Mazza JA, Clermont A, PetitClerc C, Danzig M. Ann Allergy; 1994 Sep; 73(3):235-9. PubMed ID: 8092558 [Abstract] [Full Text] [Related]
11. Comparative effects of loratadine and azatadine in the treatment of seasonal allergic rhinitis. Katelaris C. Asian Pac J Allergy Immunol; 1990 Dec; 8(2):103-7. PubMed ID: 1982614 [Abstract] [Full Text] [Related]
12. Onset-of-action for antihistamine and decongestant combinations during an outdoor challenge. Georgitis JW, Meltzer EO, Kaliner M, Weiler J, Berkowitz R. Ann Allergy Asthma Immunol; 2000 Apr; 84(4):451-9. PubMed ID: 10795655 [Abstract] [Full Text] [Related]
13. Rupatadine 10 mg and ebastine 10 mg in seasonal allergic rhinitis: a comparison study. Guadaño EM, Serra-Batlles J, Meseguer J, Castillo JA, De Molina M, Valero A, Picado C, Rupatadine Study Group. Allergy; 2004 Jul; 59(7):766-71. PubMed ID: 15180765 [Abstract] [Full Text] [Related]
14. Efficacy and safety of loratadine (10 mg once daily), terfenadine (60 mg twice daily), and placebo in the treatment of seasonal allergic rhinitis. Del Carpio J, Kabbash L, Turenne Y, Prevost M, Hebert J, Bedard PM, Nedilski M, Gutkowski A, Schulz J. J Allergy Clin Immunol; 1989 Nov; 84(5 Pt 1):741-6. PubMed ID: 2572617 [Abstract] [Full Text] [Related]
15. A randomized, double-blind, parallel-group study, comparing the efficacy and safety of rupatadine (20 and 10 mg), a new PAF and H1 receptor-specific histamine antagonist, to loratadine 10 mg in the treatment of seasonal allergic rhinitis. Saint-Martin F, Dumur JP, Pérez I, Izquierdo I, French Rupatadine-Rhinitis Study Group. J Investig Allergol Clin Immunol; 2004 Nov; 14(1):34-40. PubMed ID: 15160440 [Abstract] [Full Text] [Related]
16. Concomitant montelukast and loratadine as treatment for seasonal allergic rhinitis: a randomized, placebo-controlled clinical trial. Meltzer EO, Malmstrom K, Lu S, Prenner BM, Wei LX, Weinstein SF, Wolfe JD, Reiss TF. J Allergy Clin Immunol; 2000 May; 105(5):917-22. PubMed ID: 10808172 [Abstract] [Full Text] [Related]
18. Efficacy and safety of ebastine 20 mg compared to loratadine 10 mg once daily in the treatment of seasonal allergic rhinitis: a randomized, double-blind, placebo-controlled study. Ratner P, Hampel F, Van Bavel J, Howland W. Int Arch Allergy Immunol; 2004 Apr; 133(4):371-9. PubMed ID: 15031611 [Abstract] [Full Text] [Related]
19. Loratadine (SCH29851) 40 mg once daily versus terfenadine 60 mg twice daily in the treatment of seasonal allergic rhinitis. Bruttmann G, Pedrali P. J Int Med Res; 1987 Apr; 15(2):63-70. PubMed ID: 2884152 [Abstract] [Full Text] [Related]
20. Comparative study of SCH 434 and CTM-D in the treatment of seasonal allergic rhinitis. Prevost M, Turenne Y, Moote DW, Mazza J, Clermont A, PetitClerc C, Danzig MR. Clin Ther; 1994 Apr; 16(1):50-6. PubMed ID: 7911402 [Abstract] [Full Text] [Related] Page: [Next] [New Search]